全ゲノムシーケンシングの市場規模、シェア、予測、動向分析：オファリング別（ライブラリー調製、DNA抽出）、シーケンシングタイプ別（大規模、小規模、フェーズド）、技術別（SBS、SMRT、ナノポア、ナノボール）、用途別、エンドユーザー別 - 2031年までの世界予測

世界の全ゲノムシーケンシング市場は、2024年から2031年までのCAGRが15.2%で、2031年までに71億7,000万米ドルに達すると予測されています。

広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、課題、機会の分析から構成されています。スパイロメーター市場の成長は、シーケンシングのコスト低下、がんおよび遺伝性疾患の有病率の増加、疾患診断および精密医療における全ゲノムシーケンシングの利用拡大、医薬品研究開発費の増加、全ゲノムシーケンシングに関する規制および償還シナリオの改善、医療費の増加、研究活動への資金提供の増加、疾患の早期発見および予防に対するニーズの高まり、シーケンシング製品の技術的進歩、臨床および研究用途でのシーケンシングの利用を促進する政府の取り組みによってもたらされます。しかし、全ゲノムシーケンシング消耗品のコストが高いこと、精密医療のためのポジティブで実用的な変異を特定できる可能性が低いこと、全ゲノムシーケンシングに基づく診断に関連する倫理的・法的問題がこの市場の成長を抑制しています。

さらに、全ゲノムシーケンシングの用途の増加、大規模ゲノムシーケンシングプロジェクトに対する政府の支援、および新興国は、この市場で事業を展開するプレーヤーに成長機会をもたらすと予想されます。しかし、規制状況における不確実性、中小規模のラボの限られた専門知識とシーケンス能力、新興国におけるシーケンスの専門家の不足、NGSセットアップに必要な高額な設備投資が、市場成長の大きな課題となっています。

当レポートでは、4年間（2021年～2024年）の製品ポートフォリオの提供、地域情勢、業界をリードする市場プレイヤーが採用した主な戦略展開の広範な評価に基づく競合情勢を提供しています。世界の全ゲノムシーケンシング市場で事業を展開している主要企業は、Illumina, Inc.（米国）、Thermo Fisher Scientific, Inc.（米国）、QIAGEN N.V.（オランダ）、F. Hoffmann-La Roche Ltd.（スイス）、PerkinElmer, Inc.（米国）、Agilent Technologies, Inc.（米国）、Pacific Biosciences of California Inc.（米国）、Danaher Corporation（米国）、Bio-Rad Laboratories, Inc.（米国）、Oxford Nanopore Technologies Plc.（英国）、MGI Tech Co., Ltd.（中国）、Beijing Genomics Institute（BGI）（中国）です。

本レポートで調査したすべてのオファリングの中で、消耗品セグメントは全ゲノムシーケンシング市場で70.1%超の最大シェアを占めると予想されます。このセグメントの大きな市場シェアは、消耗品の反復的な使用、試薬および標的濃縮プロトコールと関連消耗品の継続的な進歩、および臨床環境における全ゲノムシーケンシングの応用の増加に起因すると考えられます。

本レポートで調査したすべてのシーケンスタイプの中で、2024年には全ゲノムシーケンシングセグメントが全ゲノムシーケンシング市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、大規模な全ゲノムシーケンシングがゲノムの高解像度と塩基ごとのビューを提供し、集団レベルの研究を提供するための大規模ゲノムのシーケンスに役立つためです。

本レポートで調査したすべての技術の中で、2024年には合成によるシーケンスセグメントが全ゲノムシーケンシング市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、高精度を提供し、ペアエンドライブラリーとシングルレッドライブラリーの両方をサポートし、高分解能ゲノムシーケンスを可能にする合成によるシーケンス技術が広く採用されているためと考えられます。

本レポートで調査したすべての用途の中で、2024年には研究用途分野が全ゲノムシーケンシング市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、新規創薬ターゲットの同定に全ゲノムシーケンシングが使用されるようになっていること、遺伝子ベースの医薬品に対する需要が高まっていること、医薬品研究開発活動への投資が増加していることに起因しています。

本レポートで調査したすべてのエンドユーザーの中で、2024年には製薬・バイオテクノロジー企業セグメントが全ゲノムシーケンシング市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、製薬企業およびバイオテクノロジー企業による研究開発費の増加と、これらの業界における全ゲノムシーケンシングの採用に拍車をかけている遺伝性疾患の罹患率の上昇によるものと考えられます。

世界の全ゲノムシーケンシング市場の地域別シナリオの詳細分析では、5つの主要地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）の詳細な定性的・定量的洞察を、各地域の主要国のカバレッジとともに提供しています。2024年には、北米が全ゲノムシーケンシング市場で52.1%以上の最大シェアを占めると予測されています。2024年の同地域では、米国が北米の全ゲノムシーケンシング市場で最大のシェアを占めると予想されます。北米の大きな市場シェアは、全ゲノムシーケンシングに対する高い認知度、ゲノム研究を支援する有利な政府の取り組み、NGSベースの研究用途の増加、シーケンスコストの低下、がんの高い有病率、支援的な償還シナリオなどの要因に起因します。

調査範囲：

全ゲノムシーケンシング市場の評価：オファリング別

• 消耗品
  • サンプル調製キット・試薬
• 核酸抽出・増幅
• ライブラリー調製・ターゲット濃縮
• 品質管理
• その他の消耗品
• 機器
• ソフトウェア
• サービス

注：その他の消耗品には、バイアル、ピペット、容器、トレイ、シーケンス試薬、フローセル、チューブなどが含まれます。

全ゲノムシーケンシング市場の評価：シーケンスタイプ別

• 大規模全ゲノムシーケンシング
• 小規模全ゲノムシーケンシング
• ヒト全ゲノムシーケンシング
• その他の全ゲノムシーケンシングタイプ

注：その他のホールゲノムシーケンスタイプには、デノボシーケンス、フェーズドシーケンス、ロングリードシーケンス、クローンバイクローンシーケンスが含まれます。

全ゲノムシーケンシング市場の評価：技術別

• 合成によるシーケンス
• イオン半導体シーケンス
• DNAナノボールシーケンス
• 単一分子リアルタイムシーケンス
• その他のNGS技術

注：その他の全ゲノムシーケンシング技術には、ナノポアシーケンシング、AVITIシーケンス（Avidity base chemistry（ABC））が含まれます。

全ゲノムシーケンシング市場の評価：用途別

• 研究・その他の用途
  • 創薬
  • 農業・動物研究
  • その他の用途
• 臨床用途
  • 生殖医療
  • 腫瘍学
  • 感染症
  • その他の臨床用途

注：その他の用途には、食品微生物学、飲料産業における微生物叢分析、環境調査などが含まれます。

その他の臨床用途には、神経疾患、希少疾患、代謝・免疫疾患、食品媒介性疾患における遺伝子異常の検出が含まれます。

全ゲノムシーケンシング市場の評価<：エンドユーザー別/p>

• 製薬企業・バイオテクノロジー企業
• 病院・診断研究所
• 学術機関・研究センター
• その他のエンドユーザー

注：その他のエンドユーザーには、主に法医学研究所・セキュリティ機関、食品・飲料会社、農業会社が含まれます。

全ゲノムシーケンシング市場の評価：地域別

• 北米
• 米国
• カナダ
• 欧州
• ドイツ
• フランス
• 英国
• イタリア
• スペイン
• その他欧州（RoE）
• アジア太平洋
• 日本
• 中国
• インド
• オーストラリア
• 韓国
• その他アジア太平洋（RoAPAC）
• ラテンアメリカ
• ブラジル
• メキシコ
• その他ラテンアメリカ（RoLATM）
• 中東・アフリカ

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

• 概要
• 市場成長への影響要因
  • 市場力学の影響分析
  • 要因分析
• 価格分析
• 技術動向
  • 新興シーケンス企業が技術向上とコスト削減に注力
    • Singular Genomics Systems, Inc.（米国）
    • Ultima Genomics, Inc.（米国）
    • Element Biosciences（米国）
  • 主要市場参入企業によるポータブルおよびリアルタイムシーケンス技術の重視
• 規制分析
  • 北米
    • 米国
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
• ポーターのファイブフォース分析

第5章 全ゲノムシーケンシング市場の評価：オファリング別

• 概要
• 消耗品
  • サンプル調製用消耗品
    • ライブラリー調製・ターゲット濃縮用消耗品
    • 核酸抽出・増幅用消耗品
    • 品質管理用消耗品
    • その他キット・試薬
  • その他の消耗品
• 機器
• ソフトウェア
• サービス

第6章 全ゲノムシーケンシング市場の評価：シーケンスタイプ別

• 概要
• 大規模全ゲノムシーケンシング
• 小規模全ゲノムシーケンシング
• フェーズドシーケンス
• その他の全ゲノムシーケンシングタイプ

第7章 全ゲノムシーケンシング市場の評価：用途別

• 概要
• 研究・その他の用途
  • 創薬
  • 農業・動物研究
  • その他の用途
• 臨床用途
  • 腫瘍学
  • 生殖医療
  • 感染症
  • その他の臨床用途

第8章 全ゲノムシーケンシング市場の評価：技術別

• 概要
• 合成によるシーケンス（SBS）
• イオン半導体シーケンス
• 1分子リアルタイムシーケンス
• DNAナノボールシーケンス
• その他の全ゲノムシーケンシング技術

第9章 全ゲノムシーケンシング市場の評価：エンドユーザー別

• 概要
• 製薬・バイオテクノロジー企業
• 病院・診断研究所
• 学術・研究機関
• その他のエンドユーザー

第10章 全ゲノムシーケンシング市場の評価：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第11章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 市場差別化要因
  • 先行企業
  • 新興企業
• 市場シェア分析（2023年）
  • Illumina, Inc.（U.S.）
  • Thermo Fisher Scientific Inc.（U.S.）
  • MGI Tech Co., Ltd.（China）

第12章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略的展開、SWOT分析*）

• Illumina, Inc.（U.S.）
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• QIAGEN N.V.
• Agilent Technologies, Inc.
• Revvity, Inc.
• Pacific Biosciences of California Inc.
• Danaher Corporation
• Oxford Nanopore Technologies Plc.
• MGI Tech Co., Ltd.

（注：上位5社のSWOT分析を提供します）

第13章 付録

LIST OF TABLES

• Table 1 Global Number of New Cancer Cases, by Type, 2022 Vs. 2040
• Table 2 Common Genetic Disorders: Rates of Occurrence
• Table 4 Major Genome Sequencing Projects, by Country
• Table 5 Health Expenditure, by Country, 2020-2022 (USD)
• Table 6 Whole Genome Sequencing Kits & Reagents: Pricing
• Table 7 Whole Genome Sequencing Instruments: Product Description & Pricing
• Table 9 Ug 100 Specifications
• Table 10 Aviti Specifications
• Table 11 Regulatory Authorities Governing In Vitro Diagnostics, by Country/Region
• Table 12 Global Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 13 Global Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 14 Global Whole Genome Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 16 Global Sample Preparation Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global Library Preparation & Target Enrichment Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global Nucleic Acid Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global Quality Control Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 20 Global Other Kits & Reagents Market, by Country/Region, 2022-2031" (USD Million)
• Table 21 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 22 Some of The Companies offering NGS Instruments for Whole Genome Sequencing are as Follows:
• Table 23 Global Whole Genome Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
• Table 24 Key Players offering DNA Sequencing Software
• Table 25 Global Whole Genome Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
• Table 26 Key Players offering Instrument-Related Services
• Table 27 Global Whole Genome Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
• Table 28 Global Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 29 Global Large Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 30 Global Small Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 31 Global Phased Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 32 Global Other Whole Genome Sequencing Types Market, by Country/ Region, 2022-2031 (USD Million)
• Table 33 Global Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 34 Global Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 35 Global Whole Genome Sequencing Market for Research & Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 36 Global Whole Genome Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
• Table 37 Global Whole Genome Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
• Table 38 Global Whole Genome Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 39 Global Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 40 Global Whole Genome Sequencing Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 41 Global Whole Genome Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
• Table 42 Global Whole Genome Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
• Table 43 HIV Prevalence Among Adults, by Region (2020 Vs. 2022) (In Million)
• Table 44 Global Whole Genome Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
• Table 45 Global Whole Genome Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 46 Global Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 47 Global Whole Genome Sequencing Market for Sequencing by Synthesis, by Country/Region, 2022-2031 (USD Million)
• Table 48 Global Whole Genome Sequencing Market for Ion Semiconductor Sequencing, by Country/Region, 2022-2031 (USD Million)
• Table 49 Global Whole Genome Sequencing Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2022-2031 (USD Million)
• Table 50 Global Whole Genome Sequencing Market for DNA Nanoball Sequencing, by Country/Region, 2022-2031 (USD Million)
• Table 51 Global Whole Genome Sequencing Marker for Other Whole Genome Sequencing Technologies, by Country/Region, 2022-2031 (USD Million)
• Table 52 Global Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 53 Global Whole Genome Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
• Table 54 Global Whole Genome Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
• Table 55 Global Whole Genome Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
• Table 56 Global Whole Genome Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
• Table 57 Global Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 58 North America: Whole Genome Sequencing Market, by Country, 2022-2031 (USD Million)
• Table 59 North America: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 60 North America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 61 North America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 62 North America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 63 North America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 64 North America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 65 North America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 66 North America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 67 North America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 68 U.S.: Key Macroindicators & Microindicators
• Table 69 U.S.: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 70 U.S.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 71 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 72 U.S.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 73 U.S.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 74 U.S.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 75 U.S.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 76 U.S.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 77 U.S.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 78 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments And Genome Canada Contributions, Are As Follows:
• Table 79 Canada: Key Macroindicators & Microindicators
• Table 80 Canada: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 81 Canada: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 82 Canada: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 83 Canada: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 84 Canada: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 85 Canada: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 86 Canada: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 87 Canada: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 88 Canada: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 89 Europe: Whole Genome Sequencing Market, by Country/Region, 2022-2031(USD Million)
• Table 90 Europe: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 91 Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 92 Europe: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 93 Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 94 Europe: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 95 Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 96 Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 97 Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 98 Europe: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 99 Germany: Key Macroindicators & Microindicators
• Table 100 Germany: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 101 Germany: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 102 Germany: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
• Table 103 Germany: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 104 Germany: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 105 Germany: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 106 Germany: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 107 Germany: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 108 Germany: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 109 France: Key Macroindicators & Microindicators
• Table 110 France: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 111 France: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 112 France: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 113 France: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 114 France: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 115 France: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 116 France: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 117 France: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 118 France: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 119 U.K.: Key Macroindicators & Microindicators
• Table 120 U.K.: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 121 U.K.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 122 U.K.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 123 U.K.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 124 U.K.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 125 U.K.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 126 U.K.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 127 U.K.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 128 U.K.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 129 Italy: Key Macroindicators & Microindicators
• Table 130 Italy: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 131 Italy: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 132 Italy: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 133 Italy: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 134 Italy: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 135 Italy: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 136 Italy: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 137 Italy: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 138 Italy: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 139 Spain: Key Macroindicators & Microindicators
• Table 140 Spain: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 141 Spain: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 142 Spain: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 143 Spain: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 144 Spain: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 145 Spain: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 146 Spain: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 147 Spain: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 148 Spain: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 149 Number of Sequences in Each Phase And Other Related Sequencing Information In Switzerland
• Table 150 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
• Table 151 Rest of Europe: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
• Table 152 Rest of Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 153 Rest of Europe: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
• Table 154 Rest of Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 155 Rest of Europe: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 156 Rest of Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 157 Rest of Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 158 Rest of Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 159 Rest of Europe: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
• Table 160 Asia-Pacific: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 161 Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
• Table 162 Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 163 Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
• Table 164 Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 165 Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 166 Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 167 Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 168 Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 169 Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
• Table 170 China: Key Macroindicators & Microindicators
• Table 171 China: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 172 China: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 173 China: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 174 China: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 175 China: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 176 China: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 177 China: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 178 China: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 179 China: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 180 Japan: Key Macroindicators & Microindicators
• Table 181 Japan: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 182 Japan: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 183 Japan: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 184 Japan: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 185 Japan: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 186 Japan: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 187 Japan: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 188 Japan: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 189 Japan: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 190 India: Key Macroindicators & Microindicators
• Table 191 India: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 192 India: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 193 India: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 194 India: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 195 India: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 196 India: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 197 India: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 198 India: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 199 India: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 200 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
• Table 201 Projects Funded by Australian Genomics, As Part of Its Genomic Implementation Projects In 2022 And 2023
• Table 202 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 203 Rest of Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 204 Rest of Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 205 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 206 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 207 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 208 Rest of Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 209 Rest of Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 210 Rest of Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 211 Latin America: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 212 Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
• Table 213 Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 214 Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 215 Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 216 Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 217 Latin America: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 218 Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 219 Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 220 Latin America: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
• Table 221 Brazil: Key Macroindicators & Microindicators
• Table 222 Brazil: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 223 Brazil: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 224 Brazil: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 225 Brazil: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 226 Brazil: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 227 Brazil: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 228 Brazil: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 229 Brazil: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 230 Brazil: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 231 Mexico: Key Macroindicators & Microindicators
• Table 232 Mexico: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 233 Mexico: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
• Table 234 Mexico: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 235 Mexico: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
• Table 236 Mexico: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
• Table 237 Mexico: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
• Table 238 Mexico: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 239 Mexico: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 240 Mexico: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 241 Rest of Latin America: Number of New Cancer Cases, by Country, 2022 Vs. 2030
• Table 242 Rest of Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 243 Rest of Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 244 Rest of Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 245 Rest of Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 246 Rest of Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 247 Rest of Latin America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 248 Rest of Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 249 Rest of Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 250 Rest of Latin America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 251 Middle East & Africa: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 252 Middle East & Africa: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 253 Middle East & Africa: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 254 Middle East & Africa: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
• Table 255 Middle East & Africa: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 256 Middle East & Africa: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 257 Middle East & Africa: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 258 Middle East & Africa: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 259 Middle East & Africa: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)

LIST OF FIGURES

• Figure 1 Key Stakeholders
• Figure 2 Research Process
• Figure 3 Secondary Sources Referenced for This Study
• Figure 4 Primary Research Techniques
• Figure 5 Key Executives Interviewed
• Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
• Figure 7 Market Sizing and Growth forecast Approach
• Figure 8 Global Whole Genome Sequencing Market, by Offering, 2024 Vs. 2031 (USD Million)
• Figure 9 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
• Figure 10 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
• Figure 11 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
• Figure 12 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
• Figure 13 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
• Figure 14 Global Whole Genome Sequencing Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2024-2031)
• Figure 15 Global Share of Cancer Cases, by Region, 2022 Vs. 2040 (%)
• Figure 16 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2020 Vs. 2021 (USD Million)
• Figure 17 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
• Figure 18 Percentage of Approved Personalized Medicines: Cancer Vs. Rare Diseases Vs. Other Diseases, 2022
• Figure 19 USFDA Regulatory Pathways for IVD Kits
• Figure 20 Eu Regulatory Pathway - IVDR 2017/746
• Figure 21 China: Medical Device Classification and Premarket Requirements for IVD Products
• Figure 22 Porter's Five forces Analysis
• Figure 23 Global Whole Genome Sequencing Market, by Offering, 2022 Vs. 2031 (USD Million)
• Figure 24 Steps of Sample Preparation In A Typical Next-Generation Sequencing Workflow
• Figure 25 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
• Figure 26 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
• Figure 27 U.S.: New Molecular Entity (NME) Approvals
• Figure 28 Estimated Number of New Cancer Cases (Million)
• Figure 29 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
• Figure 30 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
• Figure 31 Global Pharmaceutical R&D Spending, 2014-2026 (USD Million)
• Figure 32 Pharmaceutical Spending In 2021 Vs. 2022 (In % of Health Spending)
• Figure 33 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
• Figure 34 North America: Whole Genome Sequencing Market Snapshot
• Figure 35 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
• Figure 36 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
• Figure 37 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
• Figure 38 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
• Figure 39 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
• Figure 40 Europe: Whole Genome Sequencing Market Snapshot
• Figure 41 Italy: Number of Biotechnology Firms, 2014-2022
• Figure 42 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
• Figure 43 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
• Figure 44 Asia-Pacific: Whole Genome Sequencing Market Snapshot
• Figure 45 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
• Figure 46 Japan: Number of New Molecular Entities Approved, 2014-2022
• Figure 47 Latin America: Whole Genome Sequencing Market Snapshot
• Figure 48 Key Growth Strategies Adopted by Leading Players, 2021- 2024
• Figure 49 Global Whole Genome Sequencing Market: Competitive Benchmarking by Offering
• Figure 50 Global Whole Genome Sequencing Market: Competitive Benchmarking, by Region
• Figure 51 Competitive Dashboard: Global Whole Genome Sequencing Market
• Figure 52 Global Whole Genome Sequencing Market Share Analysis, by Key Players, 2023 (%)
• Figure 53 Illumina, Inc.: Financial Snapshot (2023)
• Figure 54 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
• Figure 55 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
• Figure 56 QIAGEN N.V: Financial Snapshot (2023)
• Figure 57 Agilent Technologies, Inc.: Financial Snapshot (2023)
• Figure 58 Revvity, Inc.: Financial Snapshot (2023)
• Figure 59 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
• Figure 60 Danaher Corporation: Financial Snapshot (2023)
• Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
• Figure 62 MGI Tech Co., Ltd.: Financial Snapshot (2023)

The global whole genome sequencing market is projected to reach $7.17 billion by 2031 at a CAGR of 15.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the declining costs of sequencing, the increasing prevalence of cancer & genetic disorders, the growing utilization of whole genome sequencing in disease diagnostics & precision medicine, increasing pharmaceutical R&D expenditures, improvements in regulatory & reimbursement scenarios for whole genome sequencing, rising healthcare expenditures, increasing funding for research activities, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of whole genome sequencing consumables, the low chances of identifying positive, actionable mutations for precision medicine, and the ethical & legal issues related to whole genome sequencing-based diagnosis restrain the growth of this market.

Furthermore, increasing applications of whole genome sequencing, government support for large-scale genomic sequencing projects, and emerging economies are expected to generate growth opportunities for the players operating in this market. However, the uncertainties in the regulatory landscape, the limited expertise & sequencing capabilities of small & medium-sized laboratories, the lack of sequencing professionals in developing countries, and the high capital investments required for NGS setups pose a major challenge to market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global whole genome sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K),MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China).

Among all the offerings studied in this report, the consumables segment is expected to account for the largest share of over 70.1% of the whole genome sequencing market. This segment's large market share can be attributed to the recurring use of consumables, continuous advancements in reagents and target enrichment protocols and associated consumables, and the increasing applications of whole genome sequencing in clinical settings.

Among all the sequencing types studied in this report, in 2024, the whole genome sequencing segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the large whole genome sequencing provides high resolution and base-by-base view of the genome and helps in sequencing large genome for providing population-level studies.

Among all the technologies studied in this report, in 2024, the sequencing by synthesis segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the widespread adoption of sequencing by synthesis technology, which offers high accuracy and supports both paired-end and single-read libraries, enabling high-resolution genome sequencing.

Among all the applications studied in this report, in 2024, the research applications segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share is attributed to the increasing use of whole genome sequencing to identify novel drug targets, the rising demand for gene-based medicines, and growing investments in drug research and development activities.

Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to increased R&D spending by pharmaceutical and biotechnology firms, along with the rising incidence of genetic diseases, which is fueling the adoption of whole genome sequencing in these industries.

An in-depth analysis of the geographical scenario of the global whole genome sequencing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 52.1% of the whole genome sequencing market. In the region in 2024, the U.S. is expected to account for the largest share of the whole genome sequencing market in North America. North America's significant market share can be attributed to factors such as high awareness of whole genome sequencing, favorable government initiatives supporting genomics research, increasing applications of NGS-based research, decreasing sequencing costs, a high prevalence of cancer, and a supportive reimbursement scenario.

Scope of the Report:

Whole Genome Sequencing Market Assessment- by Offering

• Consumables
  • Sample Preparation Kits & Reagents
• Nucleic Acid Extraction & Amplification
• Library Preparation & Target Enrichment
• Quality Control
• Other Consumables
• Instruments
• Software
• Services

Note: Other consumables include vials, pipettes, containers, trays, sequencing reagents, flow cells, and tubes.

Whole Genome Sequencing Market Assessment- by Sequencing Type

• Large Whole-Genome Sequencing
• Small Whole-Genome Sequencing
• Human Whole-Genome Sequencing
• Other Whole-Genome Sequencing Types

Note: Other Whole-genome sequencing types include De novo sequencing, Phased sequencing, Long-read sequencing, and Clone-by-clone sequencing.

Whole Genome Sequencing Market Assessment- by Technology

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• DNA Nanoball Sequencing
• Single-molecule Real-time Sequencing
• Other NGS Technologies

Note: Other whole genome sequencing technologies include nanopore sequencing and AVITI sequencing (Avidity base chemistry (ABC).

Whole Genome Sequencing Market Assessment-by Application

• Research and Other Applications
  • Drug Discovery
  • Agriculture and Animal Research
  • Other Applications
• Clinical Applications
  • Reproductive Health
  • Oncology
  • Infectious Diseases
  • Other Clinical Applications

Note: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.

Whole Genome Sequencing Market Assessment-by End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Academic Institutes & Research Centers
• Other End Users

Note: Other end users primarily include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

Whole Genome Sequencing Market Assessment-by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Rest of Europe (RoE)
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific (RoAPAC)
• Latin America
• Brazil
• Mexico
• Rest of Latin America (RoLATM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency And Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Market Share Analysis
  • 2.3.3. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
  • 4.2.2. Factor Analysis
• 4.3. Pricing Analysis
• 4.4. Technology Trends
  • 4.4.1. Emerging Sequencing Companies' Focus on Improving Technologies and Reducing Costs
    • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
    • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
    • 4.4.1.3. Element Biosciences (U.S.)
  • 4.4.2. Key Market Players' Emphasis on Portable and Real-Time Sequencing Technologies
• 4.5. Regulatory Analysis
  • 4.5.1. North America
    • 4.5.1.1. U.S.
  • 4.5.2. Europe
  • 4.5.3. Asia-Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East
• 4.6. Porter's Five Forces Analysis

5. Whole Genome Sequencing Market Assessment-by Offering

• 5.1. Overview
• 5.2. Consumables
  • 5.2.1. Sample Preparation Consumables
    • 5.2.1.1. Library Preparation & Target Enrichment Consumables
    • 5.2.1.2. Nucleic Acid Extraction & Amplification Consumables
    • 5.2.1.3. Quality Control Consumables
    • 5.2.1.4. Other Kits & Reagents
  • 5.2.2. Other Consumables
• 5.3. Instruments
• 5.4. Software
• 5.5. Services

6. Whole Genome Sequencing Market Assessment-by Sequencing Type

• 6.1. Overview
• 6.2. Large Whole-Genome Sequencing
• 6.3. Small Whole-Genome Sequencing
• 6.4. Phased Sequencing
• 6.5. Other Whole-Genome Sequencing Types

7. Whole Genome Sequencing Market Assessment-by Application

• 7.1. Overview
• 7.2. Research & Other Applications
  • 7.2.1. Drug Discovery
  • 7.2.2. Agricultural & Animal Research
  • 7.2.3. Other Applications
• 7.3. Clinical Applications
  • 7.3.1. Oncology
  • 7.3.2. Reproductive Health
  • 7.3.3. Infectious Diseases
  • 7.3.4. Other Clinical Applications

8. Whole Genome Sequencing Market Assessment-by Technology

• 8.1. Overview
• 8.2. Sequencing by Synthesis (SBS)
• 8.3. Ion Semiconductor Sequencing
• 8.4. Single-Molecule Real-Time Sequencing
• 8.5. DNA Nanoball Sequencing
• 8.6. Other Whole Genome Sequencing Technologies

9. Whole Genome Sequencing Market Assessment-by End User

• 9.1. Overview
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Hospitals & Diagnostic Laboratories
• 9.4. Academic & Research Institutes
• 9.5. Other End Users

10. Whole Genome Sequencing Market Assessment-by Geography

• 10.1. Overview
• 10.2. North America
  • 10.2.1. U.S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Rest of Europe
• 10.4. Asia-Pacific
  • 10.4.1. China
  • 10.4.2. Japan
  • 10.4.3. India
  • 10.4.4. Rest of Asia-Pacific
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Middle East & Africa

11. Competition Analysis

• 11.1. Overview
• 11.2. Key Growth Strategies
• 11.3. Competitive Benchmarking
• 11.4. Competitive Dashboard
  • 11.4.1. Industry Leaders
  • 11.4.2. Market Differentiators
  • 11.4.3. Vanguards
  • 11.4.4. Emerging Companies
• 11.5. Market Share Analysis (2023)
  • 11.5.1. Illumina, Inc. (U.S.)
  • 11.5.2. Thermo Fisher Scientific Inc. (U.S.)
  • 11.5.3. MGI Tech Co., Ltd. (China)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 12.1. Illumina, Inc. (U.S.)
• 12.2. Thermo Fisher Scientific Inc.
• 12.3. F. Hoffmann-La Roche Ltd
• 12.4. QIAGEN N.V.
• 12.5. Agilent Technologies, Inc.
• 12.6. Revvity, Inc.
• 12.7. Pacific Biosciences of California Inc.
• 12.8. Danaher Corporation
• 12.9. Oxford Nanopore Technologies Plc.
• 12.10. MGI Tech Co., Ltd.

(Note: SWOT analyses of the top 5 companies will be provided.)

13. Appendix

• 13.1. Available Customization
• 13.2. Related Reports